Market Overview

Inform Diagnostics GI Pathologists Recognized by AACC for Outstanding Research Abstract

Share:

A research abstract authored by pathologists at Inform Diagnostics has
been awarded "Outstanding Abstract" in the 2018 Therapeutic Drug
Management and Toxicology Division Abstract Competition conducted by the
American Association for Clinical Chemistry (AACC).

Titled "Therapeutic
Drug Monitoring of Monoclonal Antibody in Inflammatory Bowel Disease:
Laboratory Evidence to Predict Patient Responses
," the abstract
describes a study of 18,837 sera samples collected from adult and
pediatric IBD patients receiving monoclonal antibody (mAb) biologic drug
treatments that were analyzed using Inform Diagnostics' assay, which
employs an ELISA-based method to measure concentrations of both the drug
and patient immunity to the drug (anti-drug antibodies). This study
provides laboratory evidence to predict patient response and guide
treatment for IBD patients. The authors are Yun
Wang, PhD
, Kevin
Turner, DO
, Ahmed
Bedeir, MD
, Parag
Patel, DO
, and James
Gulizia, MD, PhD
.

The Outstanding Abstract award was presented at the AACC Therapeutic
Drug Management and Toxicology Division Annual Meeting on Monday, July
30.

About Inform Diagnostics

Inform Diagnostics is the largest independent anatomic pathology lab in
the United States, chosen by clinicians every day as a vital provider
for their patients' care. Headquartered in Irving, Texas, the
organization was founded in 1996 and previously known as Miraca Life
Sciences since 2012. Inform Diagnostics' premier medical laboratories
focus on GI pathology, dermatopathology, hematopathology, urologic
pathology, and breast pathology. Each Inform Diagnostics pathologist is
a fellowship-trained subspecialist. Learn more online about Inform
Diagnostics' extraordinary
quality and service
.

View Comments and Join the Discussion!